Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases

MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.Clin Genet 2008: 74: 307–315. © Blackwell Munksgaard, 2008MicroRNAs (miRNAs) consist of a class of evolutionarily conserved small non-coding RNA that regulates target messenger RNAs by mechanisms such as incomplete base pairing and post-transcriptional gene silencing. Recent studies have shown that aberrant miRNA expression is a common feature of many human disorders including aging, heart diseases, cancer, autoimmune diseases and others. It seems likely that miRNA expression levels can be used as novel diagnostic markers. MiRNAs may also provide a new strategy for therapeutic interventions. In this review, we focus on recent advances in understanding how miRNA changes contribute to disease development and their potential as novel biomarkers and therapeutic targets for human diseases. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Clinical Genetics Wiley

MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases

Clinical Genetics , Volume 74 (4) – Oct 1, 2008

Loading next page...
 
/lp/wiley/microrna-epigenetic-alterations-predicting-biomarkers-and-therapeutic-qOeiLretB3

References (80)

Publisher
Wiley
Copyright
Journal compilation © 2008 Blackwell Munksgaard
ISSN
0009-9163
eISSN
1399-0004
DOI
10.1111/j.1399-0004.2008.01075.x
pmid
18713257
Publisher site
See Article on Publisher Site

Abstract

Wang Y, Liang Y, Lu Q. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.Clin Genet 2008: 74: 307–315. © Blackwell Munksgaard, 2008MicroRNAs (miRNAs) consist of a class of evolutionarily conserved small non-coding RNA that regulates target messenger RNAs by mechanisms such as incomplete base pairing and post-transcriptional gene silencing. Recent studies have shown that aberrant miRNA expression is a common feature of many human disorders including aging, heart diseases, cancer, autoimmune diseases and others. It seems likely that miRNA expression levels can be used as novel diagnostic markers. MiRNAs may also provide a new strategy for therapeutic interventions. In this review, we focus on recent advances in understanding how miRNA changes contribute to disease development and their potential as novel biomarkers and therapeutic targets for human diseases.

Journal

Clinical GeneticsWiley

Published: Oct 1, 2008

Keywords: aging; autoimmunity; cancer; heart disease; infectious diseases; microRNAs

There are no references for this article.